All articles by Michelle Moore

Michelle Moore

Michelle Moore joined Medical Device Network in 2023 as a trainee healthcare reporter. With a background in medical science and economics, Michelle has experience working on medical and socioeconomic research projects. She is interested in molecular biology, personalised medicine and how artificial intelligence is changing the face of healthcare. Michelle holds a BSc in Biomedical Science and an MSc in Molecular Medicine, both from the University of Sheffield, as well as an MSc(Res) in Medicine and Economics from the University of St Andrews.

Causaly secures $60 Million in series B funding

Causaly serves 12 of the top 20 pharmaceutical companies with technology that aims to expedite the drug discovery process.

Skyelarke makes public significant changes to SkyePay

The SkyePay system allows patients to receive payments for participating in clinical trials.

Labcorp forms spin-off of Fortrea

The spin-off will create a new global Phase I-IV CRO, patient access and technology solutions.

Camena bags $10m in funding from Mercia

The bioscience company has received $10m Series A financing from asset manager Mercia.